Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.
J.P. Morgan analyst Lisa Gill maintained a Hold rating on Humana (HUM – Research Report) yesterday and set a price target of $257.00. The company’s shares closed yesterday at $280.06. Gill covers the ...
The flat-out denial comes after Cigna CEO David Cordani tried to discourage persistent speculation of a Humana merger earlier ...
Humana (HUM) announced that it has named Michelle O’Hara as Chief Human Resources Officer, effective January 1, 2025. O’Hara will ...
Last December, the two companies failed to agree on a price as Cigna pursued the purchase of the Louisville-based company.